Skip to content

Sabra Healthcare SBRA Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Net margin19.2%-0.9pp20.1%-3.4pp23.5%-1.4pp24.9%+5.3pp19.5%+1.5pp
Returns
Return on equity5.7%+0.1pp5.6%-0.7pp6.3%-0.4pp6.7%+1.5pp5.1%+0.6pp
Return on invested capital9.8%+0.1pp9.6%-1.0pp10.7%
Efficiency
Asset turnover0.2×0.0×0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×
Leverage
Debt-to-equity0.0×0.0×0.0×0.0×0.0×
Net debt / EBITDA-0.2×-0.1×-0.1×+0.3×-0.4×-0.2×-0.2×-0.2×-0×+0.1×
Per Share
Book value per share$10.88-5.7%$11.54-0.5%$11.60+3.1%$11.25+0.1%$11.25-3.2%
Valuation
Market capitalization$4.85B+2.7%$4.72B+5.7%$4.47B+1.4%$4.41B+6.1%$4.16B+1.4%
Price / earnings31×+0.7×30.3×+4.8×25.5×+1.3×24.2×-5.3×29.5×-2.8×
Price / sales-0.1×6.1×+0.1×0.0×+0.2×5.8×-0.1×
Price / book1.7×+0.1×1.7×+0.1×1.6×0.0×1.6×+0.1×1.5×0.0×
EV / EBITDA10.2×0.0×10.3×+1.1×9.2×0.0×9.3×-0.5×9.7×-0.1×
Dividend yield6.1%-0.1pp6.1%-0.3pp6.4%-0.1pp6.4%-0.3pp6.8%-0.1pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Sabra Healthcare's ratios come from?
Every ratio is computed from Sabra Healthcare's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.